GlassScriptPhysician profile
Stephanie N Strode
NPI 1750471249
$715.35
in general payments reported to CMS, 2019-2025
15 companies · $463 in 2025
The $463 reported for 2025 was more than what 81% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $252 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.36 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $257.32 | 2024-2025 | Veozah |
| Biogen, INC. | $68.34 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $63.68 | 2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $46.77 | 2024 | |
| Exeltis, USA INC. | $46.50 | 2024 | Slynd |
| Hologic Sales and Service, LLC | $43.72 | 2024-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Pfizer INC. | $41.46 | 2024 | |
| Abbvie INC. | $27.55 | 2025 | |
| Organon LLC | $23.34 | 2024 | |
| Baxter Healthcare | $19.46 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $16.77 | 2024 | Prolia, Evenity |
| Vertex Pharmaceuticals Incorporated | $16.19 | 2024 | |
| Novo Nordisk INC | $15.10 | 2025 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $14.66 | 2025 | Trintellix |
| Medtronic, INC. | $14.49 | 2025 | Ligasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Strode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.